These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 15904508)
1. Minimum follow-up time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database. Tai P; Yu E; Cserni G; Vlastos G; Royce M; Kunkler I; Vinh-Hung V BMC Cancer; 2005 May; 5():48. PubMed ID: 15904508 [TBL] [Abstract][Full Text] [Related]
2. Survival of patients with metastatic breast cancer: twenty-year data from two SEER registries. Tai P; Yu E; Vinh-Hung V; Cserni G; Vlastos G BMC Cancer; 2004 Sep; 4():60. PubMed ID: 15345027 [TBL] [Abstract][Full Text] [Related]
3. Long-term survival rates of laryngeal cancer patients treated by radiation and surgery, radiation alone, and surgery alone: studied by lognormal and Kaplan-Meier survival methods. Tai P; Yu E; Shiels R; Tonita J BMC Cancer; 2005 Jan; 5():13. PubMed ID: 15683543 [TBL] [Abstract][Full Text] [Related]
4. Cure fraction estimation from the mixture cure models for grouped survival data. Yu B; Tiwari RC; Cronin KA; Feuer EJ Stat Med; 2004 Jun; 23(11):1733-47. PubMed ID: 15160405 [TBL] [Abstract][Full Text] [Related]
5. Short- and long-term cause-specific survival of patients with inflammatory breast cancer. Tai P; Yu E; Shiels R; Pacella J; Jones K; Sadikov E; Mahmood S BMC Cancer; 2005 Oct; 5():137. PubMed ID: 16242046 [TBL] [Abstract][Full Text] [Related]
6. Italian cancer figures, report 2012: Cancer in children and adolescents. ; ; Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445 [TBL] [Abstract][Full Text] [Related]
7. Methodology to predict long-term cancer survival from short-term data using Tobacco Cancer Risk and Absolute Cancer Cure models. Mould RF; Lederman M; Tai P; Wong JK Phys Med Biol; 2002 Nov; 47(22):3893-924. PubMed ID: 12476973 [TBL] [Abstract][Full Text] [Related]
8. Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers: Results From the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) Program in the United States, 1990 to 2010. Zeng C; Wen W; Morgans AK; Pao W; Shu XO; Zheng W JAMA Oncol; 2015 Apr; 1(1):88-96. PubMed ID: 26182310 [TBL] [Abstract][Full Text] [Related]
9. Current estimates of the cure fraction: a feasibility study of statistical cure for breast and colorectal cancer. Stedman MR; Feuer EJ; Mariotto AB J Natl Cancer Inst Monogr; 2014 Nov; 2014(49):244-54. PubMed ID: 25417238 [TBL] [Abstract][Full Text] [Related]
10. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Verdecchia A; Francisci S; Brenner H; Gatta G; Micheli A; Mangone L; Kunkler I; Lancet Oncol; 2007 Sep; 8(9):784-96. PubMed ID: 17714993 [TBL] [Abstract][Full Text] [Related]
11. Cancer patient survival: Surveillance, Epidemiology, and End Results Program, 1973-79. Ries LG; Pollack ES; Young JL J Natl Cancer Inst; 1983 Apr; 70(4):693-707. PubMed ID: 6572758 [TBL] [Abstract][Full Text] [Related]
12. Cure of cancer for seven cancer sites in the Flemish Region. Silversmit G; Jegou D; Vaes E; Van Hoof E; Goetghebeur E; Van Eycken L Int J Cancer; 2017 Mar; 140(5):1102-1110. PubMed ID: 27870056 [TBL] [Abstract][Full Text] [Related]
13. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival. Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247 [TBL] [Abstract][Full Text] [Related]
14. A minimum version of log-rank test for testing the existence of cancer cure using relative survival data. Yu B Biom J; 2012 Jan; 54(1):45-60. PubMed ID: 22213092 [TBL] [Abstract][Full Text] [Related]
15. Cancer survival in five continents: a worldwide population-based study (CONCORD). Coleman MP; Quaresma M; Berrino F; Lutz JM; De Angelis R; Capocaccia R; Baili P; Rachet B; Gatta G; Hakulinen T; Micheli A; Sant M; Weir HK; Elwood JM; Tsukuma H; Koifman S; E Silva GA; Francisci S; Santaquilani M; Verdecchia A; Storm HH; Young JL; Lancet Oncol; 2008 Aug; 9(8):730-56. PubMed ID: 18639491 [TBL] [Abstract][Full Text] [Related]
16. Persistent socioeconomic inequalities in cancer survival in the United States: 1973-2007 surveillance, epidemiology and end results (SEER) data for breast cancer and non-Hodgkin's lymphoma. Kato I; Booza J; Quarshie WO; Schwartz K J Registry Manag; 2012; 39(4):158-66. PubMed ID: 23493021 [TBL] [Abstract][Full Text] [Related]
17. Proportion cured models applied to 23 cancer sites in Norway. Cvancarova M; Aagnes B; Fosså SD; Lambert PC; Møller B; Bray F Int J Cancer; 2013 Apr; 132(7):1700-10. PubMed ID: 22927104 [TBL] [Abstract][Full Text] [Related]
18. Improved survival time: what can survival cure models tell us about population-based survival improvements in late-stage colorectal, ovarian, and testicular cancer? Huang L; Cronin KA; Johnson KA; Mariotto AB; Feuer EJ Cancer; 2008 May; 112(10):2289-300. PubMed ID: 18393325 [TBL] [Abstract][Full Text] [Related]
19. Trends in incidence and prognosis for head and neck cancer in the United States: a site-specific analysis of the SEER database. Carvalho AL; Nishimoto IN; Califano JA; Kowalski LP Int J Cancer; 2005 May; 114(5):806-16. PubMed ID: 15609302 [TBL] [Abstract][Full Text] [Related]
20. Cancer net survival on registry data: use of the new unbiased Pohar-Perme estimator and magnitude of the bias with the classical methods. Roche L; Danieli C; Belot A; Grosclaude P; Bouvier AM; Velten M; Iwaz J; Remontet L; Bossard N Int J Cancer; 2013 May; 132(10):2359-69. PubMed ID: 22961565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]